Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal

Imagem de Miniatura
Arquivos
art_CAVALCANTE_Genetic_ancestry_analysis_in_nonalcoholic_fatty_liver_disease_2015.PDF (952.23 KB)
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2015
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BAISHIDENG PUBLISHING GROUP INC
Autores
CAVALCANTE, Lourianne Nascimento
V, Mariana Machado
SANDES, Kiyoko Abe
CORTEZ-PINTO, Helena
LYRA, Andre Castro
Citação
WORLD JOURNAL OF HEPATOLOGY, v.7, n.10, p.1433-1438, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
AIM: To study the association between genetic ancestry, non-alcoholic fatty liver disease (NAFLD) metabolic characteristics in two cohorts of patients, from Brazil and Portugal. METHODS: We included 131 subjects from Brazil [(n = 45 with simple steatosis (S. Steatosis) and n = 86 with nonalcoholic steatohepatitis (NASH)] and 90 patients from Portugal (n = 66, S. Steatosis; n = 24, NASH). All patients had biopsy-proven NAFLD. In histologic evaluation NAFLD activity score was used to assess histology and more than 5 points defined NASH in this study. Patients were divided into two groups according to histology diagnosis: simple steatosis or non-alcoholic statohepatitis. Genetic ancestry was assessed using real-time polymerase chain reaction. Seven ancestry informative markers (AT3-I/D, LPL, Sb19.3, APO, FY-Null, PV92, and CKMM) with the greatest ethnicgeographical differential frequencies (>= 48%) were used to define genetic ancestry. Data were analyzed using R PROJECTS software. Ancestry allele frequencies between groups were analyzed by GENEPOP online and the estimation of genetic ancestry contribution was evaluated by ADMIX-95 software. The 5% alpha-error was considered as significant (P < 0.05). RESULTS: In the Brazilian sample, NASH was significantly more frequent among the elderly patients with diabetes (NASH 56 +/- 1.1 years old vs S. Steatosis 51 +/- 1.5 years old, P = 3.7 x 10(-9)), dyslipidemia (NASH 63% vs S. Steatosis 37%, P = 0.009), higher fasting glucose levels (NASH 124 +/- 5.2 vs S. Steatosis 106 +/- 5.3, P = 0.001) and Homeostatic Model of Assessment index > 2.5 [NASH 5.3 (70.8%) vs S. Steatosis 4.6 (29.2%) P = 0.04]. In the Portuguese study population, dyslipidemia was present in all patients with NASH (P = 0.03) and hypertension was present in a larger percentage of subjects in the S. Steatosis group (P = 0.003, respectively). The genetic ancestry contribution among Brazilian and Portuguese individuals with NASH was similar to those with S. Steatosis from each cohort (Brazilian cohort: P = 0.75; Portuguese cohort: P = 0.97). Nonetheless, the genetic ancestry contribution of the Brazilian and Portuguese population were different, and a greater European and Amerindian ancestry contribution was detected in the Portuguese population while a higher African genetic ancestry contribution was observed in Brazilian population of both NASH and S. Steatosis groups. CONCLUSION: There was no difference between the genetic ancestry contribution among Brazilian and Portuguese individuals with NASH and S. Steatosis from each cohort.
Palavras-chave
Ancestry, Nonalcoholic fatty liver disease, Simple steatosis, Nonalcoholic steatohepatitis, Admixed population
URI
https://observatorio.fm.usp.br/handle/OPI/29462
Referências
  1. Arnaiz-Villena A, 2013, MOL BIOL REP, V40, P1819, DOI 10.1007/s11033-012-2236-1
  2. BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288
  3. Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005
  4. Chakraborty R, 1985, GENETIC MICRODIFFERE, P171
  5. Dongiovanni P, 2013, CURR PHARM DESIGN, V19, P5219, DOI 10.2174/13816128113199990381
  6. Salgado Ana Lúcia Farias de Azevedo, 2010, Arq. Gastroenterol., V47, P165, DOI 10.1590/S0004-28032010000200009
  7. Fridman C, 2014, INT J LEGAL MED, V128, P589, DOI 10.1007/s00414-014-1023-z
  8. Hidalgo G, 2014, AM J HUM BIOL, V26, P710, DOI 10.1002/ajhb.22567
  9. Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
  10. Leite TKM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027162
  11. Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976
  12. Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138
  13. Palmer ND, 2013, HEPATOLOGY, V58, P966, DOI 10.1002/hep.26440
  14. Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148
  15. Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100
  16. RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
  17. Shriver MD, 1997, AM J HUM GENET, V60, P957
  18. Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - ODS/03